| Followers | 19 |
| Posts | 6605 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Thursday, January 09, 2025 3:27:48 PM
WQLF ANALYSIS ;
The price of the preferred shares prior to the 1 for 3 conversion on August 2, 2023. The bottom number being Volume. The price went down drastically. From around $3.00 to around $1.00 per share. If you get 3 shares at $2.00 it comes to $6.00 per share. That is the conversion amount listed for a conversion. When the company later offered 1 for 6 conversion, the price per share was around $1.00 giving a $6.00 per share conversion. The dividends would not be paid according to the company’s agreement. That vote was never consummated according to the company because it did not have enough votes. The present day price of the preferred shares is around $.90. There were shares purchased on Wednesday before trading at $1.12. If the preferred shares continue to rise the company will most likely have an offering to convert at a 1-3, at $2.00, a 1-4 at $1.50 and 1-6 at $1.00. If the preferred price reaches $3.00 then a 1-2 is probable in my opinion.
Aug 25, 2023 1.1500 1.2900 1.1000 1.2500 1.2500 69,477
Aug 24, 2023 1.4800 1.4800 1.0600 1.2900 1.2900 161,520
Aug 23, 2023 1.7800 1.7800 1.3100 1.5900 1.5900 74,984
Aug 22, 2023 2.1900 2.1900 1.3300 1.7000 1.7000 184,691
Aug 21, 2023 3.0700 3.0700 2.4900 2.6900 2.6900 55,428
Aug 18, 2023 2.9500 2.9500 2.8700 2.9500 2.9500 5,278
Aug 17, 2023 2.8900 2.9500 2.8800 2.9100 2.9100 8,014
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175643640
The price of the preferred shares prior to the 1 for 3 conversion on August 2, 2023. The bottom number being Volume. The price went down drastically. From around $3.00 to around $1.00 per share. If you get 3 shares at $2.00 it comes to $6.00 per share. That is the conversion amount listed for a conversion. When the company later offered 1 for 6 conversion, the price per share was around $1.00 giving a $6.00 per share conversion. The dividends would not be paid according to the company’s agreement. That vote was never consummated according to the company because it did not have enough votes. The present day price of the preferred shares is around $.90. There were shares purchased on Wednesday before trading at $1.12. If the preferred shares continue to rise the company will most likely have an offering to convert at a 1-3, at $2.00, a 1-4 at $1.50 and 1-6 at $1.00. If the preferred price reaches $3.00 then a 1-2 is probable in my opinion.
Aug 25, 2023 1.1500 1.2900 1.1000 1.2500 1.2500 69,477
Aug 24, 2023 1.4800 1.4800 1.0600 1.2900 1.2900 161,520
Aug 23, 2023 1.7800 1.7800 1.3100 1.5900 1.5900 74,984
Aug 22, 2023 2.1900 2.1900 1.3300 1.7000 1.7000 184,691
Aug 21, 2023 3.0700 3.0700 2.4900 2.6900 2.6900 55,428
Aug 18, 2023 2.9500 2.9500 2.8700 2.9500 2.9500 5,278
Aug 17, 2023 2.8900 2.9500 2.8800 2.9100 2.9100 8,014
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175643640
Bullish
Recent YCBD News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 09:16:17 PM
- cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum • PR Newswire (US) • 05/14/2026 08:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:06:10 PM
- cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results • PR Newswire (US) • 05/12/2026 07:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:16:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:16:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:14:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:15:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:05:49 PM
- cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare • PR Newswire (US) • 04/01/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2026 05:15:15 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/04/2026 10:24:35 PM
- cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 • PR Newswire (US) • 02/17/2026 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:16 PM
- cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results • PR Newswire (US) • 02/12/2026 10:31:00 PM
- cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum • PR Newswire (US) • 02/02/2026 02:00:00 PM
- cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways • PR Newswire (US) • 01/29/2026 05:53:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2026 02:14:20 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/20/2026 09:05:38 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/14/2026 09:18:55 PM
- cbdMD Announces Strategic Acquisition of Bluebird Botanicals • PR Newswire (US) • 01/14/2026 02:00:00 PM
